
Science & Society
$1.8 billion in NIH grant cuts hit minority health research the hardest
News of NIH funding cuts have trickled out in recent months. A new study tallies what’s been terminated.
By Sujata Gupta
Only $2.99 a month
News of NIH funding cuts have trickled out in recent months. A new study tallies what’s been terminated.
We summarize the week's scientific breakthroughs every Thursday.
People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.
An abundance of data show that SSRIs, a class of drugs commonly used as antidepressants, are effective, though, like any drug, they have risks.
As the Texas measles outbreak grows and HHS head RFK Jr. puts vaccines under new scrutiny, two experts answer questions about the public health tool.
Defining AI chatbot personality could be based on how a bot “feels” about itself or on how a person feels about the bot they’re interacting with.
Men have two birth control options: condoms and vasectomies. Why has it taken so long to develop more contraceptives?
A recent flurry of executive orders and surprise actions by the Trump administration have roiled WHO, the CDC and the international public health community.
As Trump takes office, issues of arms control, the U.S. arsenal and weapons testing will be on the radar for many nuclear weapons researchers.
After decades of study, scientists sound genuinely optimistic about the possibility of detecting primordial black holes, which might explain dark matter.
Baby Boomers may drive a drastic increase in dementia cases in coming decades, but there are steps people can take to reduce their risk.
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.
Not a subscriber?
Become one now.